Clues to improve the cost-effectiveness of radiotherapy for brain metastases from non-small cell lung cancer: cost reduction, patient selection, and better understanding of neurocognitive deterioration
- PMID: 30691278
- DOI: 10.21037/apm.2018.12.02
Clues to improve the cost-effectiveness of radiotherapy for brain metastases from non-small cell lung cancer: cost reduction, patient selection, and better understanding of neurocognitive deterioration
Comment on
-
Extra cost of brain metastases (BM) in patients with non-squamous non-small cell lung cancer (NSCLC): a French national hospital database analysis.ESMO Open. 2018 Sep 8;3(6):e000414. doi: 10.1136/esmoopen-2018-000414. eCollection 2018. ESMO Open. 2018. PMID: 30233822 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources